Skip to main content
Clinical Trials/NCT05597774
NCT05597774
Completed
N/A

Effects of Respiratory Muscle Training Combined With an Exercise Training Program in Individuals With Long-term Post-COVID-19 Symptoms

Universidad Complutense de Madrid1 site in 1 country64 target enrollmentOctober 28, 2022

Overview

Phase
N/A
Intervention
Not specified
Conditions
Covid19
Sponsor
Universidad Complutense de Madrid
Enrollment
64
Locations
1
Primary Endpoint
Change in quality of life
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The main objective of the present study is to observe the short-term effects of respiratory muscle training combined with an exercise training program on quality of life and exercise tolerance in individuals with long-term post-COVID-19 symptoms. As secondary objectives, the effects on respiratory muscle function, physical and lung function, as well as on the psychological state of these individuals.

Detailed Description

It is a double-blind randomized clinical trial study. Each participant will be randomly assigned to one of the following groups: 1) Exercise training program + Inspiratory muscle training + Expiratory muscle training, 2) Exercise training program + Sham Inspiratory muscle training + Sham Expiratory muscle training. The exercise training program will be delivered in hospital and will be applied 2 sessions per week during 8 weeks. The exercise component will be lasted for 1hour and it consisted of cardiovascular exercises. The respiratory muscle training program will be applied twice a day, 3 sessions per week during 8 weeks by a threshold device. The evening sessions will be supervised by a physiotherapist through a virtual platform. Participants received baseline assessments at the beginning of the intervention and post-intervention assessments at the end of the 8th week.

Registry
clinicaltrials.gov
Start Date
October 28, 2022
End Date
September 22, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Over 18 years who presented long-term post-COVID-19 symptoms of fatigue and dyspnoea for at least 3 months after the COVID-19 diagnosis

Exclusion Criteria

  • Progressive respiratory, neuromuscular or neurological disorders and/or psychiatric or cognitive conditions that hindered their ability to cooperate
  • Comorbidity that could interfere with the study interventions
  • Any contraindication to the training interventions
  • Previous inclusion in a rehabilitation program for their long-term post-COVID-19 symptoms (previous 3 months)

Outcomes

Primary Outcomes

Change in quality of life

Time Frame: Baseline and 1-week post-intervention (9 weeks from baseline)

Change in quality of life between baseline and post-intervention, as measured by the EuroQol-5D questionnaire which consists of 5 dimensions with 5 response options based on severity level, ranging from 1 to 5. An index score is provided, ranging from 0 (death) to 1 (full health).

Change in exercise tolerance

Time Frame: Baseline and 1-week post-intervention (9 weeks from baseline)

Change in exercise tolerance between baseline and post-intervention, as measured by a cardiopulmonary exercise test

Secondary Outcomes

  • Change in respiratory muscle function(Baseline and 1-week post-intervention (9 weeks from baseline))
  • Change in physical function(Baseline and 1-week post-intervention (9 weeks from baseline))
  • Change in pulmonary function(Baseline and 1-week post-intervention (9 weeks from baseline))
  • Change in psychological status(Baseline and 1-week post-intervention (9 weeks from baseline))

Study Sites (1)

Loading locations...

Similar Trials